ARTICLE INFO

Article Type

Original Research

Authors

Samiee-Rad   F (1)
Beheshti   A (2)
Zangivand   AA (3)
Sofiabadi   M (* 1)






(* 1) Cellular & Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
(1) Department of Pathology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
(2) Department of Dermatology, School of Medicine, Qazvin University of Medical Sciences, Qazvin , Iran
(3) School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Correspondence

Address: Physiology Department, Medicine Faculty, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Iran.
Phone: +98 (28) 33336001
Fax: +98 (28) 33324971
mohasofi@yahoo.com

Article History

Received:  September  8, 2017
Accepted:  May 2, 2018
ePublished:  May 16, 2018

BRIEF TEXT


Burns are considered as one of the major injuries worldwide, usually leading to serious medical attention and hospitalization in burned subjects [1].

... [2-7]. Douglas in 1952, developed using the human placenta layers for the first time as a temporary biological method of wound dressing followed by Sabela (1913), who used human placenta layers for healing burn wounds. The results of their studies showed that amniotic membrane inhibits the migration of polymorphonuclear leukocytes (PMN) and stimulates the tissue coverage and acceleration in the formation of granular tissue in the wound region and subsequently resulting in a faster wound healing [8]. Silver Sulfadiazine cream 1% is commonly used worldwide as a common method of dressing for partial-thickness burns or even selectively for major burns. It is more used as an antimicrobial agent compared with other compounds, like silver nitrate, sulfamilone and acetaminophen. Unfortunately, despite its beneficial effects, topical administration causes some systemic side effects, such as neutropenia, erythema, crystalluria and methemoglobinemia. Some recent studies have also shown that its use in partial-thickness burns may delay burn healing [9-12]

Our objective was to evaluate the healing of second-degree burns in male rats treated with topical application of placental amniotic membrane alone or impregnated with topical Silver sulfadiazine cream in male rats.

This study is an experimental study.

This study was conducted on 64 male Wistar rats in the Qazvin University of Medical Sciences in 2015.

Mice were randomly divided into 4 groups (N=16). The number of samples was determined based on similar studies.

Rats were kept in standard laboratory conditions (room temperature 21±2°C) with 12 h dark/light cycle and free access to food. The study was first approved by the Ethics Committee of the Qazvin University of Medical Sciences and all protocols used in this study were in accordance with the Ethical Guidelines of the Helsinki Declaration (1975). Prior burning, the hair surrounding the neck of the rats was shaved using a standard shaving machine. Animals were anesthetized by intraperitoneally injection of ketamine (40 mg/kg) (GmbH, Germany) and Xylasein (5 mg/kg) (Galway, Ireland) and a circular hot iron stomp was used for burning (about 80°C; 1.75 cm diameter) for 1 second. Second-degree burn burns was confirmed by the pathology slide and H & E eosin staining [13]. The groups included: 1. Control (simple dressing with normal saline), 2. Dressing with topical application of placental amniotic membrane, 3. Dressing with silver sulfadiazine cream (1%; Sobhan Co.). 4. Dressing with silver sulfadiazine cream plus placental amniotic membrane. The wound was cleaned and necrotic tissue was removed daily and a new dressing was employed with normal saline or the topical application of silver sulfadiazine (1 mm) or application of placental amniotic membrane impregnated with 1% silver sulfadiazine. In order to prevent the risk of infection, a medical history of women with normal pregnancy was reviewed and laboratory studies were carried out, and the subjects suspected with cancer, infectious diseases, narcotics, hepatitis B and C and HIV were excluded. Following elective cesarean section (Kosar Hospital, Qazvin), the embryonic segments were removed under the hood and then washed with Ringer's solution under sterile conditions. The amniotic layer was removed and transferred to the cold sterilized containers (4°C) and evaluated immediately. In order to remove blood and other contaminants, it was washed four times with normal saline and once with Dakins solution (Sodium Hypochlorite solution 0.25%) and then re-washed with normal saline. Each specimen was then divided into the considered parts to be transferred to the sterile containers and stored in a refrigerator (4°C). These procedures were done in less than 2 h. At the end of day 7, 14, 21 and 28 under general anesthesia, shear wave elestography (SWE) of the burn site and its surrounding was performed for microscopic evaluation. SWE was done in the same site on different days [14]. The tissue samples were fixed at 10% with brafemarin followed by passage, processing, embedding in paraffin, and cutting at a microtome setting of 5 microns. After H & E staining, the slides were evaluated with an optical microscope for the number of PMN leukocytes, fibroblasts and new blood vessels. Olympus DP25 camera was used to capture images from all samples and a blind survey was done using Cellsens software by researcher [15]. The wound surface was evaluated on days 7, 14, 21 and 28 and the following formula was used to assess the healing: Wound surface (%) = (Wound surface on the considered day * 100) × Wound surface on the first day Healing (%) = (100-wound surface (%)) The control and evaluating of the healing was done by one researcher blind to the treatments. Data was analyzed using SPSS 19 software and data analysis was done by one way ANOVA and Tukey's post hoc tests.

On the 7th day, the wound tissue contained large amounts of nicotroic mucosa mixed with inflammatory cells (mainly with PMN leukocytes) as well as degeneration of the epidermis. In addition, angiogenesis was just begun, and the early stages of the replacement of granular tissue was initiated at the beneath of dermis. Additionally, edema and inflammatory degeneration of the loose connective tissue could be seen. At this stage, PMN leukocyte count in treated animals was significantly lower than the control group (p<0.001), but there was no significant difference between the three treatment groups (Table 1). Histology of the wound 14 days after burning showed that the thickness of burn wound was decreased in all groups, however exudate fibrino-leukocytic secretions were still observed. Several chronic inflammatory cells (lymphocytes, plasma cells and macrophages) were replaced by acute inflammatory cells, and new granulomas and blood vessels were observed. At this stage and through following weeks, the number of new fibroblasts and vascular channels (except for the fourth week) was significantly higher in the treated groups than the control group (p<0.001); however, there was no significant difference between the three treatment groups (Tables 2 and 3). The percentage of wound healing on days 7, 14, 21, and 28 in the groups treated with sulfasalazine, placental amniotic membrane plus sulfasalazine and placental amniotic membrane was significantly greater than the control group (p<0.001; Table 4). Moreover, in the 21st and 28th weeks, the following factors in the placental amniotic membrane treated group were more than the control group: granulation tissue organization, fibroblast density and collagen fiber sedimentation. In addition, at the end of the 4th week, epithelialization of the central site of wound in the control group seemed still incomplete (Table 4).

In a relatively similar study, the effectiveness of dressing with placental amniotic membrane for graft donor sites in comparison with conventional antibiotic dressings (silver sulfadiazine cream) was evaluated in 42 patients with second and third-degree burns. There was no significant difference in infection rate in two methods. However, patients were more cooperated in replacing the dressing with amniotic fluid. Also, wound healing in the dressing with amniotic membrane was four days reduced [16]. In another study, Mohammadi et al. examined the effects of dressing with silver sulfadiazine and placental amniotic membrane in burn wounds. and showed that in patients with placental amniotic membrane dressing, albumin injection, analgesics, and infection were higher than the sulforadiazine group [17].

Further studies especially for third-degree burns are recommended.

The limited financial resources restricted the development of methods and the number of samples.

Due to the similar effects of the dressing with placental amniotic membrane and sulfadiazine cream in wound healing, it is recommended that they be used as an appropriate candidate for treatment of burn wounds.

The authors are sincerely thankful to all who helped us in this project.

None declared.

None declared.

This research was funded by the Vice-Chancellor of Qazvin University of Medical Sciences.

TABLES and CHARTS

Show attach file


CITIATION LINKS

[1]Demling RH. Burns and other thermal injuries. In: Unknown Author. Current surgical diagnosis and treatment. 11th Edition. New York: Medical Books/McGraw-Hill; 2002. pp. 267-81.
[2]Atiyeh BS, Amm CA, El Musa KA. Improved scar quality following primary and secondary healing of cutaneous wounds. Aesthetic Plast Surg. 2003;27(5):411-7.
[3]Finnson KW, Mc Lean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv Wound Care (New Rochelle). 2013;2(5):195-214.
[4]Atiyeh BS, Gunn SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29(2):131-48.
[5]Das S, Baker AB. Biomaterials and nanotherapeutics for enhancing skin wound healing. Front Bioeng Biotechnol. 2016;4:82.
[6]Ramirez H, Patel SB, Pastar I. The role of TGFβ signaling in wound epithelialization. Adv Wound Care (New Rochelle). 2014;3(7):482-91.
[7]Tyszkiewicz JT, Uhrynowska-Tyszkiewicz IA, Kaminski A, Dziedzic-Goclawska A. Amnion allografts prepared in the Central Tissue Bank in Warsaw. Ann Transplant. 1999;4(3-4):85-90.
[8]Rinastiti M, Harijadi, Santoso AL, Sosroseno W. Histological evaluation of rabbit gingival wound healing transplanted with human amniotic membrane. Int J Oral Maxillofac Surg. 2006;35(3):247-51.
[9]Venkataraman M, Nagarsenker M. Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSciTech. 2013;14(1):254-64.
[10]De Gracia CG. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. Burns. 2001;27(1):67-74.
[11]Lee ARC, Moon HK. Effect of topically applied silver sulfadiazine on fibroblast cell proliferation and biomechanical properties of the wound. Arch Pharm Res. 2003;26(10):855-60.
[12]Tumino G, Masuelli L, Bei R, Simonelli L, Santoro A, Francipane S. Topical treatment of chronic venous ulcers with sucralfate: A placebo controlled randomized study. Int J Mol Med. 2008;22(1):17-23.
[13]Shahabi Sh, Zahir MH, Hashemi SM, Shahrokhi S, Karimipour M, Kazem Nejad A, et al. Hyperthermia can accelerate the healing process of 2nd degree burn wounds. J Kerman Univ Med Sci. 2005;12(2):110-8. [Persian]
[14]Toussaint J, Chung WT, Osman N, Mc Clain SA, Raut V, Singer AJ. Topical antibiotic ointment versus silver-containing foam dressing for second-degree burns in swine. Acad Emerg Med. 2015;22(8):927-33.
[15]Talas DU, Nayci A, Atis S, Polat A, Comelekoglu U, Bagdatoglu C, et al. The effects of corticosteroids on the healing of tracheal anastomoses in a rat model. Pharmacol Res. 2002;45(4):299-304.
[16]Salehi SH, Asadi K, Mousavi SJ. Evolution of effective of amniotic membrane dressing vs. conventional topical antibiotic dressing of skin graft donor site in burn patients. Iran J Surg. 2011;19(1):16-23. [Persian]
[17]Mohammadi AA, Riazi H, Hasheminasab MJ, Sabet B, Mohammadi MK, Abbasi S, et al. Amniotic membrane dressing vs conventional topical antibiotic dressing in hospitalized burn patients. Iran Red Crescent Med J. 2009;11(1):66-70.
[18]Mostaque AK, Rahman KB. Comparisons of the effects of biological membrane (amnion) and silver sulfadiazine in the management of burn wounds in children. J Burn Care Res. 2011;32(2):200-9.
[19]Al-Waili N, Salom K, Al-Ghamdi AA. Honey for wound healing, ulcers, and burns, data supporting its use in clinical practice. Sci World J. 2011;11:766-87.
[20]Halim AS, Khoo TL, Yussof SJM. Biologic and synthetic skin substitutes: An overview. Indian J Plast Surg. 2010;43(Suppl):S23-8.
[21]Park WC, Tseng SC. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci. 2000;41(10):2906-14.
[22]Al-Waili NS. Effects of honey on the urinary total nitrite and prostaglandins concentration. Int Urol Nephrol. 2005;37(1):107-11.
[23]Kobayashi N, Kabuyama Y, Sasaki S, Kato K, Homma Y. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21(1):62-7.
[24] Yam HF, Pang CP, Fan DS, Fan BJ, Yu EY, Lam DS. Growth factor changes in ex vivo expansion of human limbal epithelial cells on human amniotic membrane. Cornea. 2002;21(1):101-5.
[25]Cho Lee AR, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials. 2005;26(22):4670-6.
[26]Du Toit DF, Page BJ. An in vitro evaluation of the cell toxicity of honey and silver dressings. J Wound Care. 2009;18(9):383-9.
[27]Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci. 2017;96:243-54.